ID
26009
Description
Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01611727
Link
https://clinicaltrials.gov/show/NCT01611727
Keywords
Versions (2)
- 10/2/17 10/2/17 -
- 10/4/17 10/4/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 4, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility BRCA1 Mutation NCT01611727
Eligibility BRCA1 Mutation NCT01611727
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Chemotherapy Platinum Based
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0032207
- UMLS CUI [1,3]
- C1705938
Similar models
Eligibility BRCA1 Mutation NCT01611727
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0346993 (UMLS CUI [3,1])
C1513040 (UMLS CUI [3,2])
C3899965 (UMLS CUI [4])
C1550543 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0332185 (UMLS CUI [1,2])
C1115804 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C1115804 (UMLS CUI [2,3])
C0678226 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C1115804 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0002170 (UMLS CUI [3,2])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0032207 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])